Vimarsana
Biggest News Aggregation in the World

Page 2 - Psychedelics Studies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Psychedelics Studies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Psychedelics Studies Today - Breaking & Trending Today

Single-Dose Psilocybin Treatment for Major Depressive Disorder - Vimarsana News

Single-Dose Psilocybin Treatment for Major Depressive Disorder

This randomized clinical trial examines the timing of onset of action, durability of benefit, and safety profile of single-dose psilocybin in patients with majo

Is the therapeutic potential of hallucinogens risky and overhyped? - Vimarsana News

Is the therapeutic potential of hallucinogens risky and overhyped?

As the medicinal use of psychedelics gains mainstream attention, fears remain over their effect on mental health and the need for safe administration

Mets owner donates $5 million for research on psychedelic drugs - Vimarsana News

Mets owner donates $5 million for research on psychedelic drugs

Steve and Alexandra Cohen have donated funds to the Multidisciplinary Association for Psychedelics Studies to help MDMA be approved for PTSD treatment.

Steve Cohen donates $5M for psychedelics like MDMA, ecstacy's push to go mainstream - Vimarsana News

Steve Cohen donates $5M for psychedelics like MDMA, ecstacy's push to go mainstream

The billionaire's family foundation has pledged a total of $60 million toward psychedelics projects

Psyched: Compass, Atai And MindMed Release Q1 Earnings, Phase 3 MDMA Trial Closer To Completion, Enveric Splits Into Two Companies - Vimarsana News

Psyched: Compass, Atai And MindMed Release Q1 Earnings, Phase 3 MDMA Trial Closer To Completion, Enveric Splits Into Two Companies

The psychedelics space got a new glimpse at the financials of some of its heavy hitters with the release of earnings reports for the first quarter...